A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

333

Participants

Timeline

Start Date

January 16, 2014

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Estrogen Receptor Positive Breast Cancer
Interventions
DRUG

AZD2014

Oral tablet

DRUG

Everolimus

Oral tablet

DRUG

Fulvestrant

Im injection

Trial Locations (79)

Unknown

ICO Paul Papin, Angers

Institut Sainte Catherine, Avignon

Antoine Lacassagne Centre De Lutte Contre Le Cancer De Nice, Nice

Hospital Center Private Saint-Grégoire, Saint-Grégoire

Centre Paul Strauss, Strasbourg

Clinic Health House, Tbilisi

Institute of Clinical Oncology, Tbilisi

S. Khechinashvili University Clinic, Tbilisi

Tbilisi Cancer Center, Tbilisi

Frauenärztliche Gemeinschaftspraxis - Onkologie, Braunschweig

Kliniken Essen-Mitte Senologie, Essen

Klinik für Gynäkologie & Geburtshilfe/Brustzentrum, Frankfurt

Praxis für interdisziplinäre Onkologie & Hämatologie, Freiburg im Breisgau

MediProjekt GbR Hannover, Hannover

SLK-Kliniken Heilbronn GmbH, Heilbronn

Dokusan GmbH, Herne

St. Vincentius Kliniken, Karlsruhe

Schwerpunktpraxis Hämatologie / Onkologie MVZ Lahr, Lahr

Klinikum Neumarkt, Neumarkt

Onkologische Praxis, Oldenburg

Praxis für Innere Medizin, Singen

MVZ Klinik Dr. Hancken GmbH, Stade

Mutterhaus der Borromäerinnen, Trier

Schwarzwald Baar Klinikum, Villingen-Schwenningen, Villingen-Schwenningen

Uzsoki Street Hospital, Budapest

Bacs-Kiskun County Hospital, Kalocsa

University of Pecs, Institute of Oncology, Pécs

Zala County Szent Rafael Hospital, Zalaegerszeg

Hospital da Luz, Lisbon

Ipo Porto, Porto

Center of Oncology Euroclinic, Bucharest

Oncology Center Sf Nectarie, Caracal

Cluj County Clinical Emergency Hospital, Clinical Department of Medical Oncology, Cluj-Napoca

"Oncology Institute Prof. Dr. Ion Chiricuta", Cluj-Napoca

Oncology Center Oncolab Craiova, Craiova

National Cancer Center South Korea, Goyang

Korea University Medical Center Guro Hospital, Seoul

Yonsei University Health System, Seoul

Hospital Universitari Vall D'Hebron, Barcelona

Instituto Oncologico Dr. Rosell, Barcelona

Consorcio Hospitalario Provincial de Castellon, Castelló

Cafeteria Hospital San Pedro de Alcantara, Cáceres

Hospital Ico Josep Trueta, Girona

University Hospital Arnau de Vilanova, Lleida

Hospital Clinico Universitario San Carlos, Madrid

Hospital Son Llàtzer, Palma

Hospital Son Espases, Palma de Mallorca

Hospital Universitario de Canarias, San Cristóbal de La Laguna

Hospital Universitari Sant Joan de Reus, Tarragona

Wansbeck General Hospital, Ashington

Princess of Wales Hospital, Bridgend

Royal Sussex County Hospital, Brighton

Kent and Canterbury Hospital, Canterbury

Cumberland Infirmary, Carlisle

Broomfield Hospital, Chelmsford

University Hospital of North Durham, Durham

Calderdale Royal Hospital, Halifax

Huddersfield Royal Infirmary, Huddersfield

Kidderminster Hospital, Kidderminster

Royal Glamorgan Hospital, Llantrisant

Charring Cross Hospital, London

King's College Hospital, London

Mount Vernon Hospital, London

Queen Elizabeth Hospital, Woolwich, London

Saint Bartholomew's Hospital, London

The Royal Free Hospital, London

The Kent Oncology Centre, Maidstone

North Tyneside General Hospital, North Shields

Nottingham City Hospital, Nottingham

Derriford Hospital, Plymouth

Weston Park Hospital, Sheffield

Solihull Hospital, Solihull

Southend University Hospital, Southend-on-Sea

Royal Stoke University Hospital, Stoke-on-Trent

King's Mill Hospital, Sutton in Ashfield

Great Western Hospital, Swindon

Wrexham Maelor, Wrexham

Yeovil District Hospital, Yeovil

EC1M6BQ

Queen Mary University of London, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Queen Mary University of London

OTHER